¥20.64   ( %)
前日收盘:20.07 当日成交量(股):29.35万 当日最高:20.77 总股本:3948.00万
当日开盘:20.00 当日成交额(元):601.06万 当日最低:19.60 流通股本:
市盈率(动/静):-4.57/0 市净率:4.38 市销率:0 总市值:7.92亿
52周最高:22.40 52周最低:3.40 转让方式: 单位:美元
$ROCKET PHARMACEUTICALS(RCKT)$
  • 还可以输入
  • 20016

ROCKET PHARMACEUTICALS(RCKT) 05月21日 01时41分

新闻 Rocket Pharmaceuticals Announces Strategic Research Collaboration
- Agreement to Support the Advancement of Fanconi Anemia and PyruvateKinase Deficiency Gene Therapy Rese ......  url.vc.watch/ftj1
查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月21日 01时41分

新闻 Rocket Pharmaceuticals Presents Updated Data from Phase 1/2 Gene Therapy Trial of RP-L102 in Patients with Fanconi Anemia at the American Society of Gene & Cell Thera ......  url.vc.watch/ftjk
查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月19日 15时59分

新闻 BRIEF-Rocket Pharmaceuticals Presents Updated Data From Phase 1/2 Gene Therapy Trial Of Rp-L102
May 18 (Reuters) - Rocket Pharmaceuticals Inc (RCKT.O) : * ROCKET PHA ......  url.vc.watch/f2Wd
查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月19日 04时22分

查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月12日 20时01分

新闻 Rocket Pharmaceuticals to Present at Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--RocketPharmaceuticals, Inc. (NASDAQ:RCKT) ("Rocket"), a leading ......  url.vc.watch/fgY1
查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月12日 20时01分

新闻 Rocket Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
Four Gene Therapy Programs Potentially in Clinic in 2019 withClinical Data ......  url.vc.watch/fgYQ
查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月12日 04时30分

查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月01日 11时03分

查看全文

ROCKET PHARMACEUTICALS(RCKT) 05月01日 08时38分

新闻 Rocket Pharmaceuticals Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Rocket Pharmaceuticals Announces Presentations at ......  url.vc.watch/fLG2
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月14日 11时02分

查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月05日 11时01分

查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时03分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:WONG RODERICK
公告日:2018-04-02, 内部交易人:WONG RODERICK, 与发行人关系:董事/10%持股人/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009131, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009131/0000899243-18-009131-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时03分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:SOUTHWELL DAVID P
公告日:2018-04-02, 内部交易人:SOUTHWELL DAVID P, 与发行人关系:董事/, 操作码:M,21875(股)Common Stock; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009127, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/0000899243-18-009127-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时03分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Yalamanchi Naveen
公告日:2018-04-02, 内部交易人:Yalamanchi Naveen, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009125, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009125/0000899243-18-009125-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:GRANADILLO PEDRO P
公告日:2018-04-02, 内部交易人:GRANADILLO PEDRO P, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009124, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009124/0000899243-18-009124-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:BOESS CARSTEN
公告日:2018-04-02, 内部交易人:BOESS CARSTEN, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009120, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009120/0000899243-18-009120-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Shah Gaurav
公告日:2018-04-02, 内部交易人:Shah Gaurav, 与发行人关系:See Remarks/董事/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009118, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009118/0000899243-18-009118-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Makker Gotham
公告日:2018-04-02, 内部交易人:Makker Gotham, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009117, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009117/0000899243-18-009117-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Patel Kinnari
公告日:2018-04-02, 内部交易人:Patel Kinnari, 与发行人关系:Chief Operating Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009113, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009113/0000899243-18-009113-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文

ROCKET PHARMACEUTICALS(RCKT) 04月03日 11时02分

公告 ROCKET PHARMACEUTICALS, INC. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Militello John
公告日:2018-04-02, 内部交易人:Militello John, 与发行人关系:See Remarks/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-03-29, SEC Accession No. 0000899243-18-009112, File:https://www.sec.gov/Archives/edgar/data/1281895/000089924318009112/0000899243-18-009112-index.htm $ROCKET PHARMACEUTICALS(RCKT)$
查看全文
  • 首页 上一页 1 2 下一页 尾页  每页20条/共37